Camp4 Therapeutics Corp.

CAMP03 Dec 2024
Healthcare
$4.8
+0.06 (+5.85%)
Lowest Today
$4.23
Highest Today
$5.14
Today’s Open
$4.8
Prev. Close
$4.79
52 Week High
$12.3
52 Week Low
$4.06
To Invest in Camp4 Therapeutics Corp.

Camp4 Therapeutics Corp.

Healthcare
CAMP03 Dec 2024
+0.06 (+5.85%)
1M
3M
6M
1Y
5Y
Low
$4.23
Day’s Range
High
$5.14
4.23
52 Week Low
$4.06
52-Week Range
52 Week High
$12.3
4.06
1 Day
-
1 Week
+4.58%
1 month return
-38.4%
3 month return
-53.9%
6 month return
+419.34%
1 Year return
-
3 Years return
-
5 Years return
-
10 Years return
-

Market Status

Fundamentals
Market Cap
0
PB Ratio
0
PE Ratio
0
Enterprise Value
0
Total Assets
54.95 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001 for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP to treat synaptic Ras GTPase activating protein 1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Organisation
Camp4 Therapeutics Corp.
Employees
58
Industry
Biotechnology
CEO
Mr. Joshua  Mandel-Brehm
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step